Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Oncology: what's new in 2023].
Jankovic J, Abdelhamid K, Berthold D, Desbaillets N, Bouchaab H, Dei Tos G, Demicheli R, Diciolla A, Digklia A, Ferraro DA, Florez L, Galli-Vareia I, Hottinger A, Latifyan S, Liapi A, Mederos N, Giacomuzzi Moore B, Sakr R, Stamatiou A, Wagner AD, Peters S, Sarivalasis A, Vanniere F, Zaman K, Stravodimou A. Jankovic J, et al. Among authors: mederos n. Rev Med Suisse. 2024 Jan 17;20(856-7):80-87. doi: 10.53738/REVMED.2024.20.856-7.80. Rev Med Suisse. 2024. PMID: 38231107 French.
Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial.
da Silva Lopes AM, Colomer-Lahiguera S, Darnac C, Giacomini S, Bugeia S, Gutknecht G, Spurrier-Bernard G, Cuendet M, Muet F, Aedo-Lopez V, Mederos N, Michielin O, Addeo A, Latifyan S, Eicher M. da Silva Lopes AM, et al. Among authors: mederos n. JMIR Res Protoc. 2023 Oct 18;12:e48386. doi: 10.2196/48386. JMIR Res Protoc. 2023. PMID: 37851498 Free PMC article.
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors.
da Silva Lopes AM, Colomer-Lahiguera S, Darnac C, Giacomini S, Bugeia S, Gutknecht G, Spurrier-Bernard G, Aedo-Lopez V, Mederos N, Latifyan S, Addedo A, Michielin O, Eicher M. da Silva Lopes AM, et al. Among authors: mederos n. Support Care Cancer. 2023 Jul 22;31(8):484. doi: 10.1007/s00520-023-07934-w. Support Care Cancer. 2023. PMID: 37480546 Free PMC article. Clinical Trial.
[Salivary gland cancer: new therapeutic approaches].
Herrera Gomez RG, Mederos N, Szturz P, Degrauwe N, Jankovic J, Cristina V. Herrera Gomez RG, et al. Among authors: mederos n. Rev Med Suisse. 2023 May 17;19(827):958-963. doi: 10.53738/REVMED.2023.19.827.958. Rev Med Suisse. 2023. PMID: 37195109 French.
A Synergistic pH-Responsive Serum Albumin-Based Drug Delivery System Loaded with Doxorubicin and Pentacyclic Triterpene Betulinic Acid for Potential Treatment of NSCLC.
Torres-Martinez Z, Pérez D, Torres G, Estrada S, Correa C, Mederos N, Velazquez K, Castillo B, Griebenow K, Delgado Y. Torres-Martinez Z, et al. Among authors: mederos n. BioTech (Basel). 2023 Jan 26;12(1):13. doi: 10.3390/biotech12010013. BioTech (Basel). 2023. PMID: 36810440 Free PMC article.
[Oncology: what's new in 2022].
Nguyen-Ngoc T, Abdelhamid K, Degrauwe N, Galland S, Serena A, Christofis M, Mederos N, Bouchaab H, Diciolla A, Dris N, Orcurto A, Perrinjaquet C, Schnetz M, Latifyan S, Wetterwald L, Herrera Gómez RG, Cristina V, Sarivalasis A, Michielin O, Berthold D, Digklia A, Wagner AD, Zaman K, Peters S, Stravodimou A. Nguyen-Ngoc T, et al. Among authors: mederos n. Rev Med Suisse. 2023 Jan 18;19(N° 809-10):52-57. doi: 10.53738/REVMED.2023.19.809-10.52. Rev Med Suisse. 2023. PMID: 36660838 French.
[Management of brain metastases in 2022].
Schiappacasse L, Kinj R, De Micheli R, Mederos N, Tuleasca C, Cossu G, Dunet V, Levivier M, Bourhis J, Hottinger AF. Schiappacasse L, et al. Among authors: mederos n. Rev Med Suisse. 2022 May 18;18(782):976-983. doi: 10.53738/REVMED.2022.18.782.976. Rev Med Suisse. 2022. PMID: 35583276 French.
[Targeted therapies and non-small cell carcinomas : novelties].
Stauber R, Gro S L, Nguyen-Ngoc T, Mederos N, Bouchaab H, Peters S, Abdelhamid K. Stauber R, et al. Among authors: mederos n. Rev Med Suisse. 2022 May 18;18(782):970-975. doi: 10.53738/REVMED.2022.18.782.970. Rev Med Suisse. 2022. PMID: 35583275 French.
[2021 Oncology update].
Meyer ML, Chrysou K, Stamatiou A, Gilabert M, Herrera Gomez RG, Latifyan S, Masmoudi S, Mederos N, Perrinjaquet C, Berthold D, Bouchaab H, Cristina V, Digklia A, Michielin O, Orcurto A, Sarivalasis A, Stravodimou A, Wagner AD, Zaman K, Peters S, Jankovic J. Meyer ML, et al. Among authors: mederos n. Rev Med Suisse. 2022 Feb 2;18(767):182-186. doi: 10.53738/REVMED.2022.18.767.182. Rev Med Suisse. 2022. PMID: 35107893 French.
18 results